Home/Filings/4/0001683168-22-002470
4//SEC Filing

Dye Justin 4

Accession 0001683168-22-002470

CIK 0001622879other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 4:02 PM ET

Size

7.7 KB

Accession

0001683168-22-002470

Insider Transaction Report

Form 4
Period: 2022-04-06
Dye Justin
Director
Transactions
  • Award

    Common Stock

    2022-04-07$2.03/sh+1,000$2,030148,710 total
  • Award

    Common Stock

    2022-04-06$2.05/sh+67,355$138,078147,710 total
Holdings
  • Common Stock

    (indirect: see footnote)
    9,287,500
Footnotes (2)
  • [F1]The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $2.02 to $2.12 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]Represents shares of common stock held by Dye Capital & Company ("Dye Capital"). As the general partner of Dye Capital, Mr. Dye has voting and investment control over the securities held by Dye Capital. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

Medicine Man Technologies, Inc.

CIK 0001622879

Entity typeother

Related Parties

1
  • filerCIK 0001654539

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:02 PM ET
Size
7.7 KB